Note: Ingredients listed on restricted chemical lists
EC/CAS
212-506-0/822-89-9
Name of the chemical
Hydroxyl-2-pyridone
Concentration
=1,0-<3,0
General Information
Revision date
2024-11-04
Product name
Cal1
1.2.1 Relevant identified uses
Laboratory chemicals, Refer to product literature for further details
Emergency telephone
+49(0)621-759-2203, +49(0)6131-19240
Icons in SDS
Company Information
company name
Roche Diagnostics Deutschland GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
info.dia-sds@roche.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H315, H317, H318, H332, H411
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Cal1 2
Hazard statements
H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H332 Harmful if inhaled. H411 Toxic to aquatic life with long lasting effects.
Prevention
P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ eye protection/ face protection.
Response
P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P391 Collect spillage.
Hazardous Ingredients
9002-92-0 Poly(oxy-1,2-ethanediyl), α-dodecyl-ω-hydroxy- 822-89-9 hydroxyl-2-pyridone 26172-54-3 2-methyl-2H-isothiazol-3-one hydrochloride
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Acute toxicity, Category 4 H332: Harmful if inhaled. Skin irritation, Category 2 H315: Causes skin irritation. Serious eye damage, Category 1 H318: Causes serious eye damage. Skin sensitisation, Category 1 H317: May cause an allergic skin reaction. Long-term (chronic) aquatic hazard, H411: Toxic to aquatic life with long lasting effects. Category 2 2.2 Label elements Labelling (REGULATION (EC) No 1272/2008) Hazard pictograms : Signal word : Danger Cal1 2 Hazard statements : H315 Causes skin irritation. H317 May cause an allergic skin reaction. H318 Causes serious eye damage. H332 Harmful if inhaled. H411 Toxic to aquatic life with long lasting effects. Precautionary statements : Prevention: P261 Avoid breathing dust. P264 Wash skin thoroughly after handling. P273 Avoid release to the environment. P280 Wear protective gloves/ eye protection/ face protection. Response: P305 + P351 + P338 + P310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/ doctor. P391 Collect spillage. Hazardous components which must be listed on the label: 9002-92-0 Poly(oxy-1,2-ethanediyl), α-dodecyl-ω-hydroxy- 822-89-9 hydroxyl-2-pyridone 26172-54-3 2-methyl-2H-isothiazol-3-one hydrochloride 2.3 Other hazards This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of